Quality of life of patients with psoriasis based on EQ-5D-5L questionnaire: an analysis at specialized hospital in Vietnam

Download full text PDF
DOI: https://doi.org/10.29296/25419218-2019-06-09
Issue: 
6
Year: 
2019

Nguyen Thi Thu Thuy(1), Dinh Hoang Yen(2), Doan Ngoc Bao Chau(4), Nguyen Trong Hao(4) 1-University of Medicine and Pharmacy at Ho Chi Minh city; 41-43, Dinh Tien Hoang st, Ben Nghe ward, district 1, HCMC, Vietnam 2-Ho Chi Minh city Hospital of Dermato Venerelogy; 2, Nguyen Thong st, ward 6, district 3, HCMC, Vietnam

Introduction. Psoriasis is a chronic proliferative skin inflammation associated with an immune-allergic mechanism. With long-term treatment regimen, abnormal recurrences can negatively affect the quality of life of patients. In Vietnam, the quality of life of psoriatic patients has not been fully and comprehensive researched. Objectives: To survey characteristics of psoriatic patients;To estimate quality of life (QoL) of psoriatic patients;Analyze impact factors on quality of life of psoriatic . Materials and methods. Cross-sectional study based on data collected by surveying patients with EuroQuality of life-5 Dimensions-5 Level (EQ-5D-5L) and visual analogue scale (VAS) from psoriatic patients treated at HCMC Hospital of Dermato Venerelogy, satisfying inclusion and exclusion criteria. Analyzing impact factors were performed with relevant statistical tests and multivariate linear regression model with the 95% confidence intervals, using SPSS 20.0. Results. Sample size included 310 patients with the mean age of48.84±16.27 years; the mean disease duration of 11.51±9.82 years; the male: female ratioof 1.4:1; 52.6% patients with under high school and 68.4% living in HCMC. The mean HRQoL was 0.787±0.128 (according to EQ-5D-5L) and 0.773±0.124 (according to VAS). Withthe 95% confidence interval, gender had positive correlation with HRQoL with low level (r=0.229, p=0.000). Conclusion. The mean HRQoL of psoriatic patients was accounted for 0.787±0.128 (EQ-5D-5L) and 0.773±0.124 (VAS). Gender was an impact factor on QoL.
Keywords: 
psoriasis
quality of life
EQ-5D-5L
VAS
Ho Chi Minh City Hospital of Dermato Venerelogy
References: 
  1. Kurd S.K., Richardson S.K., Gelfand J.M. Update on the epidemiology and systemic treatment of psoriasis.Expert review of clinical immunology,2007;3(2): 171-185.
  2. Miller D.W., Feldman S.R. Cost-effectiveness of moderate-to-severe psoriasis treatment.Expert opinion on pharmacotherapy, 2006; 7 (2): 157-167.
  3. Krueger G., Koo J., Lebwohl M.et al.The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership surve.Archives of Dermatology,2001;137 (3): 280-284.
  4. Szende A., Oppe M., Devlin N. (Eds.). EQ-5D-5L value sets: inventory, comparative review and user guide. Vol. 2, 2007, Springer Science & Business Media.
  5. Fanni Rencz M.D., Ahmad Moradi M. D., Gulácsi L. Health status and quality of life in patients with psoriasis: an Iranian cross-sectional survey. Archives of Iranian medicine, 2015;18(3): 153.
  6. Ko W.C., Tsai T.F., Tang C.H. Health state utility, willingness to pay, and quality of life among Taiwanese patients with psoriasis. Dermatologica Sinica, 2016; 34(4): 185-191.
  7. Yang H.J., Yang K.C. Impact of psoriasis on quality of life in Taiwan. Dermatologica Sinica, 2015;33(3): 146-150.